Continuing Education Company 30th Annual Hypertension, Diabetes, & Dyslipidemia Conference 2026

• Include:  videos + file sub vtt +  pdf, size:  GB
• Target Audience: physicians specializing in: family or general practice, internal medicine, endocrinology, geriatric medicine, lipidology, hypertension
• Sample video: contact me for sample video
• Information:

Program Objectives

As a result of this educational activity, participants should be better able to:

Formulate an efficient and effective assessment and monitoring plan of a patient’s condition as it relates to hypertension, diabetes, and dyslipidemia.

Utilize current guidelines in the diagnosis and management of diabetes, hypertension, and dyslipidemia.

Develop individualized interventions and treatment strategies for patients presenting with hypertension, diabetes, and/or dyslipidemia that will translate into improved long-term outcomes.

Target Audience

This conference is designed for physicians, nurse practitioners, physician assistants, and other related health care professionals specializing in areas of geriatric medicine, endocrinology, lipidology and/or hypertension along with those managing patients with hypertension, diabetes, and/or hyperlipidemia.

• Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

WEDNESDAY, June 3, 2026

Day 1: Focus on Diabetes

Welcome

A. Mullins, CHCP & J. Basile, MD

Standards of Care in Type 2 Diabetes in 2026

C. Low Wang, MD

Diabetes and Metabolic Associated Steatotic Liver Disease (MASLD)-Evaluation and Treatment

C. Wysham, MD

Navigating GLP-1RA and SGLT2i Use in Your Patients with Diabetes and Obesity

C. Low Wang, MD

10:15 am: BREAK

Weight Management in Those with Diabesity or Atypical Forms of Diabetes in the Adult

C. Wysham, MD

Questions for the Faculty

C. Low Wang, MD & C. Wysham, MD

Cases from the Faculty

C. Low Wang, MD & C. Wysham, MD

THURSDAY, June 4, 2026

Day 2: Focus on Hypertension

Welcome

A. Mullins, CHCP

J. Basile, MD

What’s New in Outpatient Hypertension: Clinical Pearls from the New 2025 HTN Guideline

J. Basile, MD

MRA’s (Steroidal and Non-Steroidal) and Aldosterone Synthase Inhibitors in Hypertension and Renal Disease

G. Hundemer, MD

Hypertension in Older Women; Illuminating a Bright Spot

B. Egan, MD

10:30 am: BREAK

Rethinking Primary Aldosteronism

G. Hundemer, MD

Reframing Goal BP to Align Patients and Providers on the Target

B. Egan, MD

Questions for the Faculty

J. Basile, MD, G. Hundemer, MD, & B. Egan, MD

12:30 pm: LUNCH BREAK (Working Lunch)

Cases in Hypertension

K. Bryant, MD and above faculty

FRIDAY, June 5, 2026

Day 3: Focus on Dyslipidemia

Welcome

A. Mullins, CHCP

J. Basile, MD

What’s New in the ACC/AHA Cholesterol Guidelines?

M. Blaha, MD

Applying the 2026 ACC/AHA Cholesterol Guidelines in Practice

R. Dudum, MD

What’s on the HORIZON with Lp(a): Comparing the Nearly Completed Lp(a) Trials

M. Blaha, MD

10:15 am: BREAK

Making Sense of Non-Statin Lipid-Lowering Therapies: The When and Why to Use Them

R. Dudum, MD

Questions for the Faculty

M. Blaha, MD & R. Dudum, MD

Cases in Lipids

M. Blaha, MD & R. Dudum, MD